Dr.Reddys Laboratories reported INR1.06B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Bharat Petroleum INR 6.57B 1.76B Dec/2025
Cipla INR 131.3M 9M Mar/2026
Dr.Reddys Laboratories INR 1.06B 113M Mar/2026
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
UPL INR 7.74B 210M Dec/2025